BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia MS Zabriskie, CA Eide, SK Tantravahi, NA Vellore, J Estrada, FE Nicolini, ... Cancer cell 26 (3), 428-442, 2014 | 348 | 2014 |
BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships JS Khorashad, TW Kelley, P Szankasi, CC Mason, S Soverini, LT Adrian, ... Blood, The Journal of the American Society of Hematology 121 (3), 489-498, 2013 | 258 | 2013 |
Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B TW Kelley, MM Graham, AI Doseff, RW Pomerantz, SM Lau, MC Ostrowski, ... Journal of Biological Chemistry 274 (37), 26393-26398, 1999 | 209 | 1999 |
Combining the allosteric inhibitor asciminib with ponatinib suppresses emergence of and restores efficacy against highly resistant BCR-ABL1 mutants CA Eide, MS Zabriskie, SLS Stevens, O Antelope, NA Vellore, H Than, ... Cancer Cell 36 (4), 431-443. e5, 2019 | 169 | 2019 |
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression TW Kelley, B Pohlman, P Elson, ED Hsi American journal of clinical pathology 128 (6), 958-965, 2007 | 159 | 2007 |
Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. S Tridandapani, T Kelley, M Pradhan, D Cooney, LB Justement, ... Molecular and cellular biology 17 (8), 4305, 1997 | 155 | 1997 |
Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data DH Spencer, HJ Abel, CM Lockwood, JE Payton, P Szankasi, TW Kelley, ... The Journal of molecular diagnostics 15 (1), 81-93, 2013 | 145 | 2013 |
Age-related mutations and chronic myelomonocytic leukemia CC Mason, JS Khorashad, SK Tantravahi, TW Kelley, MS Zabriskie, ... Leukemia 30 (4), 906-913, 2016 | 141 | 2016 |
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative … JV Jovanovic, A Ivey, AM Vannucchi, E Lippert, E Oppliger Leibundgut, ... Leukemia 27 (10), 2032-2039, 2013 | 129 | 2013 |
The neuropathology of West Nile virus meningoencephalitis: a report of two cases and review of the literature TW Kelley, RA Prayson, AI Ruiz, CM Isada, SM Gordon American journal of clinical pathology 119 (5), 749-753, 2003 | 115 | 2003 |
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified SA Wang, W Tam, AG Tsai, DA Arber, RP Hasserjian, JT Geyer, TI George, ... Modern Pathology 29 (8), 854-864, 2016 | 113 | 2016 |
Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells O Efimova, P Szankasi, TW Kelley PloS one 6 (1), e16013, 2011 | 112 | 2011 |
Negative signaling in B cells: SHIP Grbs Shc S Tridandapani, T Kelley, D Cooney, M Pradhan, KM Coggeshall Immunology today 18 (9), 424-427, 1997 | 105 | 1997 |
Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia EJ Duncavage, HJ Abel, P Szankasi, TW Kelley, JD Pfeifer Modern pathology 25 (6), 795-804, 2012 | 101 | 2012 |
Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study TW Kelley, EC Borden, JR Goldblum Applied Immunohistochemistry & Molecular Morphology 12 (4), 338-341, 2004 | 99 | 2004 |
T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides KE Sufficool, CM Lockwood, HJ Abel, IS Hagemann, JA Schumacher, ... Journal of the American Academy of Dermatology 73 (2), 228-236. e2, 2015 | 92 | 2015 |
Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves phosphatidylinositol 3-kinase and reactive oxygen species in human monocytes NY Bhatt, TW Kelley, VV Khramtsov, Y Wang, GK Lam, TL Clanton, ... The Journal of Immunology 169 (11), 6427-6434, 2002 | 88 | 2002 |
FcγRIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells A Jacob, D Cooney, S Tridandapani, T Kelley, KM Coggeshall Journal of Biological Chemistry 274 (19), 13704-13710, 1999 | 84 | 1999 |
Podocalyxin: a marker of blasts in acute leukemia TW Kelley, D Huntsman, KM McNagny, CD Roskelley, ED Hsix American journal of clinical pathology 124 (1), 134-142, 2005 | 73 | 2005 |
Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib W Qiang, O Antelope, MS Zabriskie, AD Pomicter, NA Vellore, P Szankasi, ... Leukemia 31 (12), 2844-2847, 2017 | 62 | 2017 |